Eltrombopag 12.5 Mg Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets & Oral suspension
Available Strengths: Tablet: 25 mg, 50 mg, 75 mg; Suspension: 12.5 mg/5 mL
Reference Brands: Promacta® (US & EU); Revolade®(EU)
Category: Hepatitis
Eltrombopag Tablets (Promacta® / Revolade® generic) are oral TPO receptor agonists for ITP, aplastic anemia, and HCV-related thrombocytopenia. Available in 25 mg, 50 mg, and 75 mg strengths. EU-GMP/USFDA compliant, ideal for B2B supply, tenders, and licensing with full CTD support.
Product Description:
Eltrombopag Tablets (Promacta® / Revolade® generic) are thrombopoietin receptor agonists indicated for chronic ITP, severe aplastic anemia, and HCV-related thrombocytopenia. Available in 25 mg, 50 mg, and 75 mg oral tablet strengths, the product is manufactured under EU-GMP and USFDA-compliant facilities. Offered for B2B supply, hospital tenders, and licensing deals, with full CTD dossiers, bioequivalence studies, and regulatory support. Eltrombopag is a key addition for companies supplying hematology and oncology portfolios in regulated and semi-regulated markets, supporting global access to thrombopoiesis-stimulating therapies.
Eltrombopag 12.5 Mg Tablet — third party manufacturing & bulk supply
Eltrombopag 12.5 Mg Tablet is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Eltrombopag 12.5 Mg Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Eltrombopag 12.5 Mg Tablet →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Eltrombopag choline is used to treat thrombocytopenia by increasing platelet production. It is commonly prescribed for chronic immune thrombocytopenia, severe aplastic anemia, and thrombocytopenia associated with chronic hepatitis C.
Eltrombopag choline is a synthetic small-molecule thrombopoietin receptor agonist formulated as a choline salt for oral administration.
Eltrombopag choline is marketed under the trade names Promacta in the USA and Revolade in the EU and UK.
Eltrombopag choline products are manufactured by multiple pharmaceutical companies, including the original innovator and licensed generic manufacturers, depending on the market.
The generic name is eltrombopag choline.
The brand names are Promacta in the USA and Revolade in the EU and UK.
Eltrombopag choline formulations are manufactured in various countries including the USA, EU, and India, depending on the approved manufacturer and regulatory authorizations.
Related Products
Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir
Strength:
Ombitasvir 12.5 mg / Paritaprevir 75 mg / Ritonavir 50 mg (tablet)+ Dasabuvir 250 mg (tablet)
Form: Tablet
Reference Brands: Viekira Pak® (US); Viekirax® + Exviera® (EU)
View Details
Ribavirin
Strength:
Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL
Form: Tablets, Capsules and Oral Solution
Reference Brands: Rebetol®, Copegus®, Virazole®(EU & US)
View Details
Adefovir Dipivoxil
Strength:
10 mg
Form: Oral tablets
Reference Brands: Hepsera® (EU & US)
View Details
Tenofovir Alafenamide (Taf)
Strength:
25 mg TAF per tablet
Form: Tablet
Reference Brands: Vemlidy (EU & US), Genvoya (India)
View DetailsQuick Response Guaranteed | Verified Suppliers
